User engagement in a digital weight-loss program yielded better results in participants taking GLP-1 receptor agonists than ...

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight loss as an ...

A recent study points to a key bone-strengthening mechanism at work in the body, which could be targeted to treat the ...

New evidence suggests there may be a critical window for hormone replacement therapy use in women to maintain estrogen levels ...

From high-tech to surprisingly simple, these picks deliver real results.

Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

Soluble TAM receptors (sTAMs) could serve as biomarkers for RA, indicating disease activity, severity, and prognosis, though standardized detection methods are needed. TAM receptors could emerge as ...

Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer ...

CAR-T stands for Chimeric Antigen Receptor T-cell therapy. Doctors harvest the patient’s T cells, the soldiers of the immune ...

From the beginning of life on Earth, microbes, small but influential single-celled organisms, have shaped the environment ...